Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway–tumour–stroma lung cancer modelChristophe Mas, Samuel Constant, Ludovic Wiszniewski et al.|Journal of Biotechnology|2015Cited by 24
Colon Cancer: Current Treatments and Preclinical Models for the Discovery and Development of New TherapiesSamuel Constant, Christophe Mas, Song Huang et al.|Drug Discovery|2013Cited by 10
Genetic engineering of a 3D in vitro human airway model sensitive to carcinogensHugo Benainous, Christophe Mas, Samuel Constant et al.|Toxicology Letters|2017Cited by 1
OncoCilAir™: A physiological in vitro platform to assess the efficacy and the toxicity of lung cancer therapeuticsHugo Benainous, Christophe Mas, Vasyl Kilin et al.|Toxicology Letters|2018Cited by 1
OncoCilAir™: A physiological in vitro platform to assess the efficacy and the toxicity of lung cancer therapeuticsChristophe Mas, Samuel Constant, Hugo Benainous et al.|New Biotechnology|2018Cited by 1